Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 312.00
-1.50 (-0.48%)
Sep 24, 2025, 5:35 PM CET
Virbac Revenue
Virbac had revenue of 738.28M EUR in the half year ending June 30, 2025, with 20.94% growth. This brings the company's revenue in the last twelve months to 1.43B, up 6.97% year-over-year. In the year 2024, Virbac had annual revenue of 1.40B with 12.07% growth.
Revenue (ttm)
1.43B
Revenue Growth
+6.97%
P/S Ratio
1.82
Revenue / Employee
225.09K
Employees
6,365
Market Cap
2.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.40B | 150.48M | 12.07% |
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | 934.20M | -4.14M | -0.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| emeis Société anonyme | 5.64B |
Virbac News
- 9 days ago - Virbac SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 9 days ago - Virbac SA (VRBCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Virbac: 2025 Half-year results - GlobeNewsWire
- 12 days ago - Virbac : Public release of the Half-Year Financial Report at 30 June 2025. - GlobeNewsWire
- 12 days ago - Virbac : Half-yearly financial report 2025 - GlobeNewsWire
- 5 weeks ago - Virbac:: Paul Martingell's compensation terms - GlobeNewsWire
- 2 months ago - Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation - GlobeNewsWire
- 3 months ago - VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025 - GlobeNewsWire